首页> 外文期刊>European urology >The Inhibitory Role of Acetylcholine and Muscarinic Receptors in Bladder Afferent Activity
【24h】

The Inhibitory Role of Acetylcholine and Muscarinic Receptors in Bladder Afferent Activity

机译:乙酰胆碱和毒蕈碱受体在膀胱传入活动中的抑制作用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The main treatment for overactive bladder (OAB) is the use of anticholinergic drugs initially believed to inhibit the effect of parasympathetic acetylcholine (ACh) on the detrusor; however, there is now evidence to suggest that anticholinergic drugs could interact with sensory pathways. Objective: Investigate the role of muscarinic receptors and ACh in modulating bladder afferent sensitivity in the mouse.Design, setting, and participants: Bladder and surrounding tissue were removed from wild-type male mice, placed in a recording chamber, and continually perfused with fresh oxygenated Krebs solution at 35 H. Bladders were cannulated to allow infusion and intravesical pressure monitoring, and afferent nerve fibres innervating the bladder were dissected and put into a suction electrode for recording. Measurements: Multiunit afferent activity and intravesical pressure were recorded at baseline and during bladder distension. Experiments were conducted in the presence of muscarinic agonists and antagonist or in the presence of the cholinesterase inhibitor physostigmine.Results and limitations: Blocking muscarinic receptors using atropine (1 |xM) had no effect on spontaneous afferent discharge, the afferent response to bladder distension, or on bladder compliance. However, stimulation of muscarinic receptors directly using bethanechol (100 |xM) and carbachol (100 (xM) or indirectly using physostigmine (10 jxM) significantly inhibited the afferent response to bladder distension and concurrently reduced bladder compliance. Furthermore, prior application of nifedipine prevented the changes in bladder tone but did not prevent the attenuation of afferent responses by bethanechol or physostigmine. Conclusions: These data indicate that stimulation of muscarinic receptor pathways can depress sensory transduction by a mechanism independent of changes in bladder tone, suggesting that muscarinic receptor pathways and ACh could contribute to normal or pathologic bladder sensation.
机译:背景:膀胱过动症(OAB)的主要治疗方法是使用抗胆碱能药物,最初认为该药物可抑制副交感神经乙酰胆碱(ACh)对逼尿肌的作用。但是,现在有证据表明抗胆碱能药物可以与感觉途径相互作用。目的:研究毒蕈碱受体和乙酰胆碱酯在调节小鼠膀胱传入敏感性中的作用。设计,环境和参与者:从野生型雄性小鼠中取出膀胱和周围组织,放置在记录室中,并连续灌注新鲜的在35 H下用氧气充入Krebs溶液。将膀胱插管以进行输液和膀胱内压监测,并解剖支配膀胱的传入神经纤维并将其放入吸引电极进行记录。测量:在基线和膀胱扩张期间记录多单位传入活动和膀胱内压。实验是在毒蕈碱激动剂和拮抗剂或胆碱酯酶抑制剂毒扁豆碱存在的情况下进行的。结果与局限性:使用阿托品(1 | xM)阻断毒蕈碱受体对自发性出院没有影响,对膀胱扩张的入院反应或膀胱顺应性。然而,直接使用苯乙二酚(100 | xM)和卡巴胆碱(100(xM)或间接使用毒扁豆碱(10 jxM)刺激毒蕈碱受体会明显抑制对膀胱扩张的传入反应,并同时降低膀胱顺应性。结论:这些数据表明,毒蕈碱受体途径的刺激可以通过与膀胱张力变化无关的机制抑制感觉传导,提示毒蕈碱受体途径和抑制途径ACh可能有助于正常或病理性膀胱感觉。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号